With investors questioning why some solvent companies are delisting from the stock exchange, Sarah picks out some of the more popular stocks that are restructuring and deploying chess manoeuvres...
Which biotech companies are performing the Night of the Long Knives, who benefits from HS2 and is blockchain the revolution that hasn't quite happened, but is on the verge of being understood?...